CME Group (CME) Q3 2025 10-Q Quarterly Report
Filed: Oct 24, 2025Period ending Sep 30, 2025
Financials
Security & Commodity Brokers, Dealers, Exchanges & ServicesSEC EDGAR CME Group (CME) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 24, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
CME Group Q3 2025 10-Q Analysis
Management Discussion & Analysis
- • Revenue $1,537.6M Q3 2025, down 3% YoY from $1,584.4M Q3 2024
- • Operating margin 63.3% Q3 2025 vs 64.6% YoY, net income $908.0M vs $912.8M, EPS $2.49 stable YoY
- • Clearing and transaction fees down 5% to $1,227.9M, market data revenue up to $202.5M (+14% YoY)
- • Cash flow from operations increased to $3,143.2M for 9 months ended Sept 2025, up from $2,672.6M
- • Management notes lower Q3 volumes due to reduced market volatility, maintains strong liquidity and ongoing $3B stock repurchase authorization
Risk Factors
- • No material changes in risk factors from 2024 10-K disclosed in this 10-Q
- • Market volatility risk remains significant due to changing economic conditions affecting trading volumes
- • Regulatory compliance risk persists with ongoing SEC and CFTC oversight and evolving derivatives regulations
- • Operational risk from technology disruptions could impact platform availability and trading execution
- • Financial risk from interest rate fluctuations affecting funding costs and investment portfolio valuation
CME Group Q3 2025 Quarterly FinancialsXBRL
Revenue
$1.5B
▼ -3.0% YoY▼ -9.1% QoQ
Net Income
$897M
▼ -0.5% YoY▼ -11.4% QoQ
Net Margin
58.3%
▲ +143bp YoY▼ -151bp QoQ
Source: XBRL data from CME Group Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on CME Group
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.